T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
MYR Group
MYRG
$5.23B
| $3.2M | ﹤0.01% |
14,635
-50
| -0.3% | -$10.9K |
|
1552
Academy Sports + Outdoors
ASO
$2.97B
| $3.17M | ﹤0.01% |
63,376
+2,072
| +3% | +$103K |
|
1553
Polaris
PII
$3.93B
| $3.17M | ﹤0.01% |
50,069
-1,214
| -2% | -$79.9K |
|
1554
Brookfield Infrastructure
BIPC
$4.98B
| $3.15M | ﹤0.01% |
69,349
+4,095
| +6% | +$185K |
|
1555
Noble Corp
NE
$7.22B
| $3.15M | ﹤0.01% |
111,406
+5,755
| +5% | +$170K |
|
1556
Veracyte
VCYT
$3.34B
| $3.14M | ﹤0.01% |
74,678
+5,881
| +9% | +$237K |
|
1557
Avnet
AVT
$7.83B
| $3.14M | ﹤0.01% |
65,287
+1,490
| +2% | +$73.2K |
|
1558
Envista
NVST
$4.54B
| $3.13M | ﹤0.01% |
144,179
+3,877
| +3% | +$79.5K |
|
1559
Sana Biotechnology
SANA
$1.02B
| $3.12M | ﹤0.01% |
766,487
+620,370
| +425% | +$2.78M |
|
1560
M/I Homes
MHO
$3.87B
| $3.12M | ﹤0.01% |
24,351
+701
| +3% | +$92.7K |
|
1561
Outfront Media
OUT
$5.33B
| $3.11M | ﹤0.01% |
129,008
+8,841
| +7% | +$184K |
|
1562
Broadstone Net Lease
BNL
$4.38B
| $3.08M | ﹤0.01% |
177,378
-309,558
| -64% | -$5.57M |
|
1563
Brighthouse Financial
BHF
$3.39B
| $3.08M | ﹤0.01% |
47,496
+3,458
| +8% | +$203K |
|
1564
Nutrien
NTR
$32.5B
| $3.06M | ﹤0.01% |
49,575
+6,273
| +14% | +$369K |
|
|
OPLN
1565
Openlane
OPLN
$4.38B
| $3.06M | ﹤0.01% |
102,695
+2,091
| +2% | +$56.6K |
|
1566
LivaNova
LIVN
$4.46B
| $3.06M | ﹤0.01% |
49,687
+2,264
| +5% | +$129K |
|
1567
Bank of Hawaii
BOH
$3.17B
| $3.04M | ﹤0.01% |
44,464
+1,932
| +5% | +$127K |
|
1568
Yeti Holdings
YETI
$3.4B
| $3.03M | ﹤0.01% |
68,547
-2,578
| -4% | -$99.2K |
|
1569
Rush Enterprises Class A
RUSHA
$9.62B
| $3.02M | ﹤0.01% |
56,038
+1,593
| +3% | +$82.8K |
|
1570
Towne Bank
TOWN
$3.51B
| $3.02M | ﹤0.01% |
90,356
+2,449
| +3% | +$82.5K |
|
1571
Community Bank
CBU
$3.46B
| $3.01M | ﹤0.01% |
52,430
+2,256
| +4% | +$130K |
|
1572
BellRing Brands
BRBR
$1.29B
| $3M | ﹤0.01% |
112,068
+9,672
| +9% | +$300K |
|
1573
SiriusXM
SIRI
$9.52B
| $2.98M | ﹤0.01% |
149,310
-1,311
| -0.9% | -$28.2K |
|
1574
Valaris
VAL
$6.04B
| $2.97M | ﹤0.01% |
58,841
-1,162
| -2% | -$62.4K |
|
1575
Shake Shack
SHAK
$3.03B
| $2.96M | ﹤0.01% |
36,522
+1,634
| +5% | +$144K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.